A2A Pharmaceuticals, Inc.'s Net Worth
Estimate Recalculated Sep 9, 2024 12:40AM EST
Who is A2A Pharmaceuticals, Inc.
A2A Pharmaceuticals, Inc. has an estimated net worth of $45.1 Million. This is based on reported shares in Biomea Fusion, Inc..
SEC CIK
A2A Pharmaceuticals, Inc.'s CIK is 0001859061
Past Insider Trading and Trends
2021 was A2A Pharmaceuticals, Inc.'s most active year for acquiring shares with 1 total transactions. A2A Pharmaceuticals, Inc.'s most active month to acquire stocks was the month of February. 2023 was A2A Pharmaceuticals, Inc.'s most active year for disposing of shares, totalling 7 transactions. A2A Pharmaceuticals, Inc.'s most active month to dispose stocks was the month of April. 2023 saw A2A Pharmaceuticals, Inc. paying a total of $6,250,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2023 A2A Pharmaceuticals, Inc. cashed out on 800,000 shares for a total of $25,758,705.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
